Wegovy in the thigh or stomach: which site actually works better?

Wegovy (semaglutide) is licensed for subcutaneous injection into the abdomen, the front of the thigh, or the upper arm — all three sites are clinically acceptable.
Absorption speed can differ slightly by site: the abdomen tends to absorb subcutaneous medicines a little faster than the thigh, though this difference rarely affects week-to-week outcomes in practice.
Rotating your injection site each week helps reduce skin reactions and the build-up of fatty lumps (lipohypertrophy) that can affect how the medicine is absorbed over time.
Neither site is universally "better" for weight loss — your prescriber will help you decide based on your anatomy, comfort, and any medicines you take alongside Wegovy.

The short answer: the thigh and the abdomen are both licensed injection sites for Wegovy, and clinical evidence does not show that one site produces meaningfully greater weight loss than the other. What matters most is rotating between sites, injecting correctly, and staying consistent week to week. That said, the two sites do behave differently in practice, and knowing why can help you choose. These are prescription-only medicines assessed and supervised by a qualified prescriber, so any questions about what suits your individual situation should go to your clinical team. The sections below walk through the real factors behind the decision.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Choosing your Wegovy injection site: what the evidence actually says

Why people think one site works better than another

A common misconception is that injecting into the stomach gets the medicine into your bloodstream faster, and that faster absorption means it works harder. It is a reasonable thought, but it is not quite how semaglutide works. Wegovy is a once-weekly injection: its effect builds gradually over the full seven days, not in the hour after you inject. Small differences in how quickly the abdomen versus the thigh absorbs the medicine do not translate into a measurable difference in how much weight you lose over weeks and months.

What does matter is the quality of the injection, reaching the subcutaneous fat layer consistently, not injecting into muscle or skin. That is true regardless of which site you use. The Wegovy overview on our site covers the broader picture of how semaglutide works as a GLP-1 receptor agonist and what drives its effects on appetite and body weight.

Comfort and confidence also matter. If you are tense about injecting into your abdomen, a tense muscle or flinch can change the injection angle. A site you use calmly and confidently is likely to give a more consistent result than the site that anxiety says is theoretically superior. It is also worth knowing that whether you take Wegovy on an empty stomach or not is a separate but related question that many people have when they are thinking about how to get the most from each dose.

Practical differences between the thigh and the abdomen

The abdomen offers a large, accessible area with typically good subcutaneous fat coverage, which is why it is the site many people start with. Injecting into the abdomen also allows you to see what you are doing easily, useful in the early weeks when you are building confidence. For more on technique and what to expect from abdominal injections, our guide to Wegovy in the stomach goes into detail on positioning and common questions.

The thigh (specifically the front and outer part, mid-thigh) is a good alternative if your abdomen is tender, has scar tissue, or if you have recently injected there. The thigh can be easier to reach if you have limited dexterity in one hand, and sitting down while injecting can stabilise the leg. Our page on injecting Wegovy in the thigh covers positioning and what to watch for at this site.

The upper arm is the third licensed site but typically requires a second person's help or a stabilising technique, so most self-injectors treat it as a rotation option rather than their primary site.

How to rotate, and why it matters more than which site you pick

Rotation is the factor that has the clearest practical impact on long-term injection quality. Using the same small patch of skin week after week can cause lipohypertrophy, a firm, fatty lump under the skin that absorbs medicine unpredictably. This is well-documented with injectable medicines generally, and the NHS semaglutide page advises changing the site with each dose.

A simple rotation pattern: abdomen left side one week, abdomen right side the next, front-left thigh the week after, front-right thigh the week after that. Some people include the upper arm when they have help. The key is spacing injections at least a few centimetres from any spot used in the past two or three weeks. If you notice a hard or lumpy area at your usual site, avoid it and speak to your prescriber.

For a full comparison of site options side by side, the Wegovy stomach or thigh page sets out the practical trade-offs clearly.

When the decision is more than a preference

For most people this is genuinely a matter of comfort and rotation logistics. But a few situations make site choice more clinically relevant. If you also inject insulin or another subcutaneous medicine, your prescriber will want to ensure different medicines go into different sites and are kept apart by a safe distance. If you have had abdominal surgery, significant scar tissue, or a hernia, the abdomen may not be the best primary site. And if skin reactions keep recurring at one site despite good rotation, your clinical team may suggest a change.

Questions about whether Wegovy is the right choice for you, or how it compares with other licensed options, are worth exploring properly. You can read about semaglutide in more detail or look at our weight-loss treatment overview to understand the full picture. If you are ready to talk to a prescriber about your own situation, you can start a free consultation with our clinical team, a GPhC-registered prescriber reads every submission and responds the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions